Medical/Pharmaceuticals

Medical Imaging Leaders Tap IBM and Watson to Tackle Cancer, Diabetes, Eye Health, Brain Disease and Heart Disease

CAMBRIDGE, Massachusetts, June 23, 2016 /PRNewswire/ -- IBM (NYSE: IB M ) today announced it has formed a Watson Health medical imaging collaborative, a global initiative comprised of more than fifteen leading health systems, academic med...

2016-06-23 01:28 2677

Emerging Medical Devices and Imaging Technologies Identified to Disrupt and Transform the Healthcare Industry

MOUNTAIN VIEW, California, June 22, 2016 /PRNewswire/ -- TechVision, Frost & Sullivan's technology consulting division, has identified 10 medical devices and imaging technologies expected to create opportunities and propel the healthcare industry in the next 18 to 24 months. These technologies ha...

2016-06-22 21:35 1752

Frontier Biotech Reports Primary Endpoint Met in Phase 2 Trial of AB001 In Chronic Low Back Pain

NANJING, China, June 22, 2016 /PRNewswire/ -- Frontier Biotechnologies Inc. today reported that a Phase 2 clinical trial for its novel patch product AB001 met primary endpoint at week-2, demonstrating statistically significant (p=0.023) and clinically meaningful pain relief against placebo. Condu...

2016-06-22 16:02 2221

Improved Healthcare Delivery Models across Africa Transform the Industry, Says Frost & Sullivan

CAPE TOWN, South Africa, June 22, 2016 /PRNewswire/ -- The pharmaceutical industry, followed closely by healthcare information technology (IT), inAfrica is predicted to experience substantial growth in 2016. A host of factors are anticipated to have a positive effect on the African healthcare ind...

2016-06-22 14:30 1341

IriSys Opens Business Development Office in Shanghai

SAN DIEGO, June 22, 2016 /PRNewswire/ -- IriSys LLC, the custom pharmaceutical development and manufacturing company, today announced that it has established a business development office inShanghai. The office is staffed byLeonard Shi, Business Development Manager. Mr. Shi is an experienced ...

2016-06-22 11:35 1968

Terumo BCT Announces a $17.4 Million Funding Contract from the Biomedical Advanced Research and Development Authority (BARDA)

LAKEWOOD, Colorado, June 22, 2016 /PRNewswire/ -- Terumo BCT, a global medical device manufacturing company, is pleased to announce that it has been awarded $17.4 million in initial funding from the Biomedical Advanced Research and Development Authority (BARDA) to initiate a clinical trial using t...

2016-06-22 03:48 2462

Scarcity of Mass Production Infrastructure Threatens Growth Opportunities in Cell-based Therapies

MOUNTAIN VIEW, Calif., June 21, 2016 /PRNewswire/ -- The fast-growing cell therapy market is attracting government and private funds, positioning disruption throughout the pharmaceutical landscape.Stem cell therapy, the largest segment, has an impressive number of clinical trials worldwide. Fu...

2016-06-21 21:35 1764

ORIG3N(TM) and Kangstem Biotech Announce Collaboration to Study Neural Stem Cells

BOSTON and SEOUL, South Korea, June 21, 2016 /PRNewswire/ -- ORIG3N, Inc ., a pioneer in regenerative medicine, and Kangstem Biotech , a developer of innovative stem-cell therapies, today announced that they have begun a scientific collabo...

2016-06-21 21:05 2246

Finesse and One Hill Solutions Release SmartLab(TM) Platform for Lab-Scale Bioprocess Optimization

SANTA CLARA, Calif., June 21, 2016 /PRNewswire/ -- Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, in partnership with One Hill Solutions, an innovative software developer inMassachusetts, announced the launch of the SmartLab pl...

2016-06-21 08:00 2012

FDA Approves PaxVax to Manufacture Vaxchora™ (Oral Cholera Vaccine) at SynCo Bio Partners

AMSTERDAM, June 20, 2016 /PRNewswire/ -- SynCo Bio Partners, a world leading GMP contract manufacturer of biopharmaceuticals, today announced that one of its customers, PaxVax, has received FDA approval for Vaxchora™, a single-dose oral, live attenuated cholera vaccine, indicated for use in adu...

2016-06-20 15:00 2795

BD and A*STAR's Singapore Immunology Network Enter Research Partnership to Advance Cell Analysis Technologies

SINGAPORE, June 20, 2016 /PRNewswire/ -- Becton Dickinson Holdings Pte Ltd (BD), a global leader in life science technologies, and the Singapore Immunology Network (SIgN) a research institute underSingapore's Agency for Science, Technology and Research (A*STAR), with expertise in immunology and ...

2016-06-20 10:00 3366

Infinitus Wins Aon Hewitt's 'Best Employer - China' Award for the Fourth Time

SHANGHAI, June 17, 2016 /PRNewswire/ -- On June 16, 2016, Infinitus (China) Co., Ltd, a member of LKK Health Products Group, won the title ofAon Hewitt's Best Employer inChina 2016 that was presented at an award ceremony held in Shanghai. Infinitus bested 108 candidates to garner one of the final...

2016-06-17 14:47 4324

Emerging Technologies Driving Disruption and Transformation in Health and Wellness

MOUNTAIN VIEW, California, June 15, 2016 /PRNewswire/ -- TechVision, Frost & Sullivan's technology consulting division, has identified new technologies impacting the health and wellness sector. These technologies offer a number of opportunities for innovative pharmaceutical and biotechnology comp...

2016-06-15 21:35 2068

Sanofi Strategic Health Project Aimed at Improving Community Chronic Disease Management Capabilities

BEIJING, June 15, 2016 /PRNewswire/ -- Today Sanofi, a global healthcare leader, announces the launch of its strategic Healthy Community Project with its partners the Chinese Medical Doctor Association, Community Health Association ofChina, China International Exchange and Promotive Association f...

2016-06-15 19:32 3314

New Dynamics Revitalize French Medical Imaging Services Market Unleashing Growth Opportunities for Unconventional Business Models

LONDON, June 15, 2016 /PRNewswire/ -- The spate of liberal radiology and public-private initiatives in the French medical imaging services market is starting to create a fertile environment for business model innovation. Several factors such as the reorganisation of regional health authoritie...

2016-06-15 17:21 1460

Mundipharma's Raman Singh Listed among Top Five in Global Power List Following a Blockbuster Year

SINGAPORE, June 15, 2016 /PRNewswire/ -- Raman Singh, President, Mundipharma Asia Pacific,Latin America, the Middle East and Africa, has been ranked the world's fourth most influential person in the pharmaceutical industry by the UK'sMedicine Maker. This comes after Mundipharma achieved year-on-y...

2016-06-15 10:56 1707

China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2016

HONG KONG, June 15, 2016 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financ...

2016-06-15 04:16 1906

Novogen Patent Covering Anisina(TM) Has Proceeded to Grant

SYDNEY, June 14, 2016 /PRNewswire/ -- US-Australian drug discovery company Novogen Ltd (ASX: NRT; NASDAQ: NVGN) today announced that a patent for the ATM-3500 series had been granted inAustralia. The ATM-3500 series includes the investigational agent known as Anisina (ATM-3507). Novogen North Am...

2016-06-14 08:30 2496

Victoza® significantly reduced the risk of major cardiovascular events and death in adults with type 2 diabetes in the LEADER trial

NEW ORLEANS, June 14, 2016 /PRNewswire/ -- This material is intended for global medical media only. For journalistic assessment and preparation before publication.  Novo Nordisk today announced that Victoza® (liraglutide) significantly reduced the risk of the composite primary endpoint of cardi...

2016-06-14 05:15 1541

Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes

NEW ORLEANS, June 13, 2016 /PRNewswire/ -- This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstracts: 293-OR, 240-OR Faster-acting insulin aspart improved postprandial glucose (PPG) control in type 1 and type 2 diabetes  ...

2016-06-13 22:00 1352
1 ... 252253254255256257258 ... 267